financetom
Business
financetom
/
Business
/
OnePlus 6T launch on October 30: Expected price, features, specifications, etc...
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OnePlus 6T launch on October 30: Expected price, features, specifications, etc...
Oct 23, 2018 8:23 AM

OnePlus is set to launch OnePlus 6T on October 30 in India. The upgrade to OnePlus 6 is not expected to offer many differentiated features.

The expected specifications of the phone are that the dual-SIM OnePlus 6T will run Android 8.1 Oreo and feature a 6.41-inch full-HD+ (1080x2340 pixels) AMOLED display along with a 19.5:9 aspect ratio. It is also rumoured to have a Qualcomm Snapdragon 845 SoC, coupled with 6GB and 8GB RAM options and up to 256GB storage. It will be equipped with dual rear camera setup along with a 20-megapixel primary sensor and a 16-megapixel secondary sensor. There could also be features such as an HDR mode and a new Night Mode.

It is expected to be priced at Rs 48,000 for 8GB RAM and 128 GB storage variant.

Reliance Digital announced its partnership with OnePlus to start selling the OnePlus 6T offline in India.

Reliance Digital will organise promotional campaigns for OnePlus products to attract more customers. The announcement comes just before the launch of the OnePlus 6T scheduled for October 29 in New York, followed by an India launch on October 30 in New Delhi.

Reliance Digital stores will sell OnePlus 6T in offline stores and the phone will also be sold online via Amazon and OnePlus store. Previously, OnePlus 6 was sold at Tata Group-owned Chroma offline stores.

Disclaimer:

RIL, the promoter of Reliance Digital, also controls Network18, the parent company of CNBCTV18.com.

First Published:Oct 23, 2018 5:23 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US mid-sized banks ride industry upswing on robust fee income
US mid-sized banks ride industry upswing on robust fee income
Jan 17, 2025
(Reuters) - A raft of U.S. banks reported higher fourth-quarter profits on Friday, extending a winning streak for the industry as an upswing in capital markets alleviated a hit from weaker loan demand. Long believed to be the stronghold of Wall Street heavy hitters such as JPMorgan Chase and Goldman Sachs, investment banking and trading have become increasingly vital for...
Red Sea trade route will remain too risky even after Gaza ceasefire deal, industry executives say
Red Sea trade route will remain too risky even after Gaza ceasefire deal, industry executives say
Jan 17, 2025
* Red Sea previously a key global gateway for consumer goods * Altered trade routes add extra days and costs for shipments * War risk insurers maintain firm rates for now - sources say By Jonathan Saul and Helen Reid LONDON, Jan 17 (Reuters) - Companies transporting their products around the world are not ready to return to the Red...
Imax Signs Deal With Netflix to Broadcast Upcoming Film Narnia
Imax Signs Deal With Netflix to Broadcast Upcoming Film Narnia
Jan 17, 2025
09:24 AM EST, 01/17/2025 (MT Newswires) -- Imax ( IMAX ) said in a regulatory filing Friday that it has signed a deal with Netflix ( NFLX ) to broadcast the upcoming film Narnia across the Imax ( IMAX ) international theater network for a two-week run beginning Thanksgiving next year. Financial terms of the deal were not disclosed. Shares...
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Jan 17, 2025
09:18 AM EST, 01/17/2025 (MT Newswires) -- Novo Nordisk's ( NVO ) Ozempic, Wegovy and Rybelsus are among the 15 additional drugs selected for US Medicare price negotiations, the Department of Health and Human Services said Friday. Novo Nordisk ( NVO ) shares were down 4.3% in premarket activity Friday. The other drugs subject to the talks are: GSK's (GSK)...
Copyright 2023-2026 - www.financetom.com All Rights Reserved